27 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Genovese, Rheumatologist in Stanford, CA?
Dr. Mark Genovese, MD is a Rheumatologist, who primarily practices in Stanford, CA with 2 additional practice locations. He has been practicing for over 27 years and is board certified. Dr. Genovese is fluent in English, and is currently seeing new patients. Dr. Genovese’s practice accepts Medicaid, Medicare, UnitedHealthcare, Aetna and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Genovese’s office at (650) 723-4000.
What are Areas of Expertise for Dr. Genovese?
Dr. Mark Genovese, MD is a highly-rated, board-certified Rheumatologist known for expertly diagnosing, treating, and managing a wide array of related conditions or procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Genovese empowers patients to confidently navigate their health journey, specializing in Arthritis, Autoimmune Disease, or comprehensive wellness support. Serving the Stanford/CA community, Dr. Genovese is dedicated to enhancing lives through expert, patient-centered care.
What languages does Dr. Genovese speak?
Dr. Genovese and their clinical team can communicate with patients in the following languages:
English
What conditions does Dr. Genovese treat?
As a Rheumatologist, Dr. Genovese diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Genovese. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.
Also known as:
- Rheumatoid Arthritis
- Adult-Onset Still's Disease
- Juvenile Arthritis
- RA
- Inflammatory Arthritis
- Autoimmune Arthritis
- Still's Disease (Adult Form)', 'Systemic Juvenile Idiopathic Arthritis (Adult)', 'Adult Still's Syndrome
- AOSD
ICD-10 Codes:
- M0560: Rheumatoid arthritis of unspecified site with involvement of other organs and systems
- M061: Adult-onset Still's disease
Also known as:
- Psoriatic Arthritis
- Psoriasis
- Psoriatic joint inflammation
- Arthritis with psoriasis
- Psoriasis-related joint pain
ICD-10 Codes:
- L4050: Arthropathic psoriasis, unspecified
Also known as:
- Granulomatous Mastitis in Right Breast
- Breast Disease
- Chronic right breast inflammation
- Idiopathic granulomatous mastitis right
- Non-infectious mastitis right breast
ICD-10 Codes:
- N6121: Granulomatous mastitis, right breast
Also known as:
- Granulomatous Mastitis in Left Breast
- Breast Disease
- Left breast inflammatory condition
- Left breast granulomatous disease
- Left breast non-infectious mastitis
ICD-10 Codes:
- N6122: Granulomatous mastitis, left breast
Which procedures does Dr. Genovese perform as a Rheumatologist?
As a Rheumatologist, procedures performed by a Dr. Mark Genovese may include:
- Abnormal ANA Testing
- Arthrocentesis
- Denosumab Injection
- Joint Aspiration
- Joint Injections
- Rheumatology Consultation
- Rheumatology Follow Up
- Viscosupplement Injections
For detailed information, please contact Dr. Genovese's office.
Does Dr. Genovese accept my insurance?
Dr. Genovese accepts most major insurance plans. Important: Please call our office at (650) 723-4000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Genovese accept in Stanford, CA?
Dr. Genovese in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Aetna
All Other Third Party
Blue Shield of California
Central California Alliance for Health
CVS Health (formerly Aetna)
Express Scripts
Medicaid
Medicare
UnitedHealthcare
Western Growers Association
View All Insurances
Where is Dr. Genovese's office located?
Recognitions
Publications
Novel small molecule therapeutics in rheumatoid arthritis
RHEUMATOLOGY, 2013
Longterm Safety and Efficacy of Tocilizumab in Patients with Rheumatoid Arthritis
JOURL OF RHEUMATOLOGY, 2013
Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding
Anls of the rheumatic diseases, 2013
Efficacy and Safety of Belimumab in Patients with Rheumatoid Arthritis: A Phase II, Randomized
JOURL OF RHEUMATOLOGY, 2013
Effects of Fostamatinib (R788), an Oral Spleen Tyrosine Kise Inhibitor
JOURL OF RHEUMATOLOGY, 2013
Tabalumab in Rheumatoid Arthritis Patients With an Idequate Response to Methotrexate
ARTHRITIS AND RHEUMATISM, 2013
Effects of sclerostin antibody on healing of a non-critical size femoral bone defect
JOURL OF ORTHOPAEDIC RESEARCH, 2013
Longterm Safety and Efficacy of Abatacept Through 5 Years of Treatment in Patients with Rheumatoid
JOURL OF RHEUMATOLOGY, 2012
Effect of Golimumab on Patient-reported Outcomes in Rheumatoid Arthritis
JOURL OF RHEUMATOLOGY, 2012
Tabalumab, an anti-BAFF monoclol antibody
Anls of the rheumatic diseases
Subcutaneous Abatacept Versus Intravenous Abatacept A Phase IIIb Noninferiority Study
ARTHRITIS AND RHEUMATISM, 2011
Atacicept in Patients With Rheumatoid Arthritis
ARTHRITIS AND RHEUMATISM, 2011
A 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy of
JOURL OF RHEUMATOLOGY, 2011
An Oral Syk Kise Inhibitor in the Treatment of Rheumatoid Arthritis A Three-Month Randomized
ARTHRITIS AND RHEUMATISM, 2011
LY2439821, a Humanized Anti-Interleukin-17 Monoclol Antibody
ARTHRITIS AND RHEUMATISM, 2010
Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients
ANLS OF THE RHEUMATIC DISEASES, 2009
First Report of Idiopathic Granulomatous Mastitis Treated with Methotrexate Monotherapy
JOURL OF RHEUMATOLOGY, 2009
Less Radiographic Progression with Adalimumab Plus Methotrexate Versus Methotrexate Monotherapy
JOURL OF RHEUMATOLOGY, 2009
Efficacy of a p38 mitogen activated protein kise inhibitor
JOURL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2009
Inhibition of p38: Has the Fat Lady Sung
ARTHRITIS AND RHEUMATISM, 2009
Blood autoantibody and cytokine profiles predict response to anti
ARTHRITIS RESEARCH & THERAPY, 2009
Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis
ARTHRITIS AND RHEUMATISM, 2008
Ocrelizumab, a humanized anti-CD20 monoclol antibody
ARTHRITIS AND RHEUMATISM, 2008
Efficacy and safety of the selective co
ANLS OF THE RHEUMATIC DISEASES, 2008
Efficacy results from pivotal clinical trials with abatacept
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007
A pilot trial of rituximab in the treatment of patients with dermatomyositis
ARCHIVES OF DERMATOLOGY, 2007
Proteomic alysis of secreted proteins in early rheumatoid arthritis
ANLS OF THE RHEUMATIC DISEASES, 2007
A pilot study of tumor necrosis factor inhibition in erosive
JOURL OF RHEUMATOLOGY, 2007
Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed
JOURL OF RHEUMATOLOGY, 2007
Selective tyrosine kise inhibition by imatinib mesylate for the treatment of autoimmune arthritis
JOURL OF CLINICAL INVESTIGATION, 2006
A randomized, blinded
JOURL OF RHEUMATOLOGY, 2005
Magement of co-morbidities and general medical conditions in patients with rheumatoid arthritis.
Current rheumatology reports, 2005
Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition
NEW ENGLAND JOURL OF MEDICINE, 2005
Antigen microarray profiling of autoantibodies in rheumatoid arthritis
ARTHRITIS AND RHEUMATISM, 2005
Longterm safety, efficacy
JOURL OF RHEUMATOLOGY, 2005
Factors that predict prematurity
AMERICAN JOURL OF OBSTETRICS AND GYNECOLOGY, 2005
Biologic therapies in clinical development for the treatment of rheumatoid arthritis
JCR-JOURL OF CLINICAL RHEUMATOLOGY, 2005
Temporal effects of a COX-2-selective NSAID on bone ingrowth
JOURL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2005
Pharmacologic modulation of periprosthetic osteolysis
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2005
Associations between rheumatoid arthritis and maligncy
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2004
Combition therapy with etanercept
ARTHRITIS AND RHEUMATISM, 2004
Treatment of rheumatoid arthritis with etanercept
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2004
Unlocking the PAD lock on rheumatoid arthritis
ANLS OF THE RHEUMATIC DISEASES, 2004
A randomized, controlled trial of interferon-beta
Arthritis research & therapy, 2004
Interleukin 1 receptor antagonist inhibits localized bone formation in vivo
JOURL OF RHEUMATOLOGY, 2003
COX-2 selective inhibitors and bone
INTERTIOL JOURL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2003
Imaging of the articular cartilage in osteoarthritis of the knee joint
JOURL OF MAGNETIC RESONCE IMAGING, 2003
Modulation of bone ingrowth
JOURL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2003
Rheumatic syndromes associated with maligncy
CURRENT OPINION IN RHEUMATOLOGY, 2003
COX-2 selective NSAID decreases bone ingrowth in vivo
JOURL OF ORTHOPAEDIC RESEARCH, 2002
Central nervous system lupus and pregncy: 11-year experience at a single center.
jourl of materl-fetal & neotal medicine, 2002
Etanercept versus methotrexate in patients with early rheumatoid arthritis - Two
ARTHRITIS AND RHEUMATISM, 2002
Long-term followup of patients treated with total lymphoid irradiation for lupus nephritis
ARTHRITIS AND RHEUMATISM, 2002
Autoantigen microarrays for multiplex characterization of autoantibody responses
TURE MEDICINE, 2002
Expression of the chemokine receptors CCR4, CCR5
AMERICAN JOURL OF PATHOLOGY, 2002
Rules of chemokine receptor association with T cell polarization in vivo
JOURL OF CLINICAL INVESTIGATION, 2001
Demyeliting and neurologic events reported in association with tumor necrosis factor alpha
ARTHRITIS AND RHEUMATISM, 2001
Treatment of rheumatoid arthritis with total lymphoid irradiation - Long-term survival
ARTHRITIS AND RHEUMATISM, 2001
Bonzo/CXCR6 expression defines type 1
JOURL OF CLINICAL INVESTIGATION, 2001
Current magement of rheumatoid arthritis
HOSPITAL PRACTICE, 2001
Cutting edge: A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal
JOURL OF IMMUNOLOGY, 2000
Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine
JOURL OF EXPERIMENTAL MEDICINE, 2000
Joint and soft-tissue injection - A useful adjuvant to systemic and local treatment
POSTGRADUATE MEDICINE, 1998
Fever, rash, and arthritis in a woman with silicone gel breast implants
WESTERN JOURL OF MEDICINE, 1997
Lemierre's syndrome
SOUTHERN MEDICAL JOURL, 1997
What is Dr. Genovese's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Genovese's National Provider Identifier (NPI) number is 1487711875.
What common questions do patients ask about Dr. Genovese?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Genovese
What is Dr. Mark Genovese's specialty?
Dr. Genovese is a Rheumatologist near Stanford, CA. An internist specializing in the treatment of diseases affecting the joints, muscles, bones, and tendons. This specialist diagnoses and manages conditions such as arthritis, back pain, muscle strains, common sports injuries, and collagen-related diseases. Contact Dr. Genovese to book an appointment today.
Is this Dr. Mark Genovese affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Genovese is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
Where can I learn more about Rheumatologist?
Explore Rheumatologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Mark Genovese accepting new patients in Stanford, CA?
Yes, Dr. Mark Genovese is accepting new patients at this time.
Does Dr. Mark Genovese offer online booking?
Please contact Dr. Genovese's office at (650) 723-4000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Mark Genovese?
Please contact Dr. Genovese's office at (650) 723-4000 for information regarding telehealth appointment availability or for scheduling assistance.
Other Rheumatologist Near Stanford, CA
Rheumatologist
Accepting patientsRheumatologist
Accepting patients
Rheumatologist
Accepting patients